PACS Group, Inc.
Close on Oct 19, 2026
- Market cap
- $7.43B
- P/E (TTM)
- 26.2
- Dividend yield
- –
Earnings
Next report expected Nov 18, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 4, 2026 | After market close | $1.43B | $0.47 | $0.63 |
| Q1 FY2026 Ended Mar 31, 2026 | May 11, 2026 | After market close | $1.42B | $0.50 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 26, 2026 | After market close | $1.36B | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 19, 2025 | After market close | $1.34B | $0.32 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Sep 11, 2025 | Before market open | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 6, 2024 | Before market open | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 12, 2024 | After market close | $981.85M | $-0.07 | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 13, 2024 | After market close | $934.70M | $0.38 | – |
Company guidance
Outlook given with results on Aug 4, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | full-year 2026 | $640.00M to $660.00M | Raised |
| revenueGAAP | 2026 | $5.75B to $5.85B | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements PACS filed with the SEC
PACS Group Announces Chief Legal Officer Transition
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PACS Group, Inc. Reports Second Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
PACS Group, Inc. Reports First Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
PACS GROUP, INC. ANNOUNCES RETIREMENT OF
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PACS GROUP, INC. ANNOUNCES THE APPOINTMENT OF CAREY P. HENDRICKSON
Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
PACS GROUP, INC. APPOINTS DR. PATRICK CONWAY, MD, MSc TO BOARD OF DIRECTORS
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PACS Group, Inc. Reports Fiscal Year and Fourth Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
PACS Group, Inc. Reports Third Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
PACS Group Announces NYSE Listing Extension and Provides Select Preliminary Interim Operating Metrics
Results of operations · EX-99.1 to Form 8-K
PACS NYSE Notice Press Release
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
PACS Reschedules Earnings Call Press Release
Results of operations · EX-99.1 to Form 8-K
PACS Group, Inc. Reports Second Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
PACS Group, Inc. Reports First Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K